About the Product

Description


Dobutake 250 Injection containing Dobutamine is used in the management of heart failure and cardiac conditions. It helps in improving heart function and increasing cardiac output in critically ill patients.

Dobutamine works by stimulating beta-1 receptors in the heart, which enhances myocardial contractility and improves blood circulation. This action supports effective cardiac performance in emergency and ICU settings.

The injection is widely used in hospitals and critical care units, leading to consistent demand in specialized medical settings.

With increasing cases of cardiac disorders and demand for critical care medicines, this product offers strong business potential for distributors and institutional suppliers. Its essential role in emergency care, high-value segment, and steady hospital demand make it a reliable product for consistent sales and growth in the cardiac segment.

Some patients may experience increased heart rate, palpitations, headache, nausea, or fluctuations in blood pressure. Rarely, arrhythmias, chest pain, or hypersensitivity reactions may occur and require immediate medical attention.

Dobutake 250 Injection is indicated for the management of acute heart failure, cardiogenic shock, and low cardiac output states, including those occurring after cardiac surgery or myocardial infarction. It helps improve cardiac output, enhance tissue perfusion, and stabilize hemodynamic conditions in critically ill patients.

This injection should be administered under strict medical supervision, usually in a hospital setting. Continuous monitoring of heart rate, blood pressure, and cardiac rhythm is essential during therapy. Use with caution in patients with arrhythmias or hypertension.

Store in a cool, dry place below 25°C, protected from light. Do not freeze. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Dobutamine 250mg Injection in the PCD pharma franchise market?

Dobutamine 250mg Injection has strong demand in the critical care and cardiology segment, making it a high-value hospital-use product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.

Why should medical distributors include Dobutamine Injection in their product range?

Medical distributors and wholesalers can benefit from consistent demand in intensive care units (ICU), heart failure management, cardiogenic shock, and emergency cardiac support. It is widely used in hospital settings under strict medical supervision.

Does Cafoli Lifecare offer PCD pharma franchise opportunities for this product?

Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Dobutamine 250mg Injection with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for this critical care product?

Wholesalers and medical agencies benefit from steady hospital procurement demand, ICU-based usage, and strong institutional sales when partnering with Cafoli Lifecare.

How can I become a distributor or franchise partner for Dobutamine Injection?

Medical distributors, stockists, wholesalers, and pharma professionals interested in this critical care formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.